Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants

Establishment Labs(®) Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11(th) World Symposium on Ergonomic Implants

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced the presentation of new clinical and scientific data supporting Breast Tissue Preservation and its Minimally Invasive Platform. Establishment Labs also announced the product line extensions of both Mia(®) and Preservé™ with new sizes and supporting tools. The announcements took place during the 11th World Symposium on Ergonomic Implants (WSEI), in Istanbul, Turkey.